dihydroxyphenylalanine has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joutsa, J | 1 |
Martikainen, K | 1 |
Niemelä, S | 1 |
Johansson, J | 1 |
Forsback, S | 1 |
Rinne, JO | 1 |
Kaasinen, V | 1 |
1 other study available for dihydroxyphenylalanine and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
Topics: Aged; Compulsive Behavior; Dihydroxyphenylalanine; Disruptive, Impulse Control, and Conduct Disorder | 2012 |